MedTrace Logo

Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

NCT05045443 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-01-08

No results posted yet for this study

Summary

Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia

Conditions

  • Acute Lymphoblastic Leukemia, Pediatric

Interventions

DRUG

Curcumin

Tumeric curcumin 500 mg per oral capsule of Puritans Pride company supplement

DIETARY_SUPPLEMENT

Standard of Care

As per institution protocol for Standard of nutritional Care

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ihab Khairy, M.D · Faculty of Medicine Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-22
Primary Completion
2022-12-31
Completion
2024-01-04

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05045443 on ClinicalTrials.gov